UBS Knock-Out SAX/ DE000UK304U7 /
03/06/2024 13:12:00 | Chg.-0.02 | Bid13:32:12 | Ask13:32:12 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.12EUR | -0.48% | 4.13 Bid Size: 20,000 |
4.14 Ask Size: 20,000 |
STROEER SE + CO. KGA... | 24.4103 EUR | 31/12/2078 | Call |
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GlobeNewswire
14:15
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-I...
GlobeNewswire
14:14
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in P...
GlobeNewswire
14:10
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution ...
GlobeNewswire
14:07
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental W...
GlobeNewswire
14:05
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at...
GlobeNewswire
14:04
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
GlobeNewswire
14:01
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
GlobeNewswire
14:00
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Tre...
GlobeNewswire
14:00
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
GlobeNewswire
14:00
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome T...